BFC Planning’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
Other funds holding ABUS
BFC Planning's ABUS Position: Q3 2026 in Review
BFC Planning opened a new position in Arbutus Biopharma (ABUS) in Q3 2026: 5,000 shares worth $23.9K. The stake represents ﹤0.01% of the portfolio and ranks #1934 among its holdings.
156 funds tracked by Wall St. Rank hold ABUS as of Q3 2026.
- BFC Planning held 5,000 shares of Arbutus Biopharma worth $23.9K as of Q3 2026.
- Arbutus Biopharma was a new BFC Planning position in Q3 2026.
- Arbutus Biopharma made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #1934 holding.
- 156 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q3 2026.
Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.